Transaction DateRecipientSharesTypePriceValue
12th October 2020Stuart M. Grant50,000Open or private purchase$3.60$180,000.00
12th October 2020Stuart M. Grant50,000Open or private purchase$3.50$175,000.00
24th September 2020Stuart M. Grant25,000Open or private purchase$2.98$74,500.00
24th September 2020Stuart M. Grant50,000Open or private purchase$3.00$150,000.00
18th September 2020Jennifer G Clasby26,737Exercise of derivative$1.95$52,137.15
11th September 2020Anthony Y Sun7,288Grant/award etc.$0.00
11th September 2020Charles E Iv Mather7,288Grant/award etc.$0.00
11th September 2020Fredric N Eshelman7,288Grant/award etc.$0.00
11th September 2020Kenneth B Jr Lee7,288Grant/award etc.$0.00
11th September 2020Ernest Mario7,288Grant/award etc.$0.00
Eyenovia logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Edenovia, Inc. engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine.

Ticker: EYEN
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1682639
Employees: 24
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags